Hair loss blog at drproctor.com
Hair loss blog mn.st hair loss treatment blog
Hair loss blog skindrugs.com blog
Hair loss blog peterproctor.com
J Dtsch Dermatol Ges. 2011 Oct;9 Suppl 6:S1-57. doi: 10.1111/j.1610-0379.2011.07802.x.
Guideline for the treatment of androgenetic alopecia in women and in men.
Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, Trakatelli M, Finner A, Kiesewetter F, Trüeb R, Rzany B, Blume-Peytavi U; European Dermatology Forum (EDF).
Department of Dermatology and Allergy, Clinical Research Center for Hair and Skin Science, Charité- Universitätsmedizin, Berlin, Germany.
Androgenetic alopecia is the most common cause of hair loss… Patients diagnosed with androgenetic alopecia may undergo significant impairment of quality of life. Despite the high prevalence and the variety of therapeutic options available, there have been no national or international evidence-based guidelines for treatment. Therefore, the European Dermatology Forum (EDF) initiated a project to develop an evidence-based S3 guideline for the treatment of hair loss due to andro-genetic alopecia…..The purpose of the guideline is to provide dermatologists as well as general practitioners with an evidence-based tool for choosing an efficacious and safe therapy for patients with androgenetic alopecia.
edited for blog use.
Oncologist. 2011 Dec 1.
The Effect of Cigarette Smoking on Cancer Treatment-Related Side Effects.
AbstractBackground. Cigarette smoking has long been implicated in cancer development and survival. However, few studies have investigated the impact of smoking on symptom burden in cancer survivors during treatment and at survivorship stage. This study examines the influence of cigarette smoking on side effects among 947 cancer patients during and 6 months following treatment.Methods. Patients diagnosed with cancer and scheduled to receive chemotherapy and/or radiation therapy reported on current smoking status (yes, no) and total symptom burden [the sum of 12 common symptoms (fatigue, hair loss, memory, nausea, depression, sleep, pain, concentration, hot flashes, weight loss, skin problems, and dyspnea) scored on an 11-point scale ranging from 0 = “not present” to 10 = “as bad as you can imagine"] during treatment and at 6-month follow-up. The adjusted mean total symptom burden by smoking status was determined by analysis of covariance controlling for age, gender, race, education, occupation, treatment, cancer site, and Karnofsky performance score.Results. During treatment, smokers (S) had a significantly higher total symptom burden than nonsmokers (NS). At 6-month follow-up, smokers continued to report a higher total symptom burden than nonsmokers. Participants who quit smoking before treatment levels had a total symptom burden similar to nonsmokers.Conclusion. Smoking was associated with an increased symptom burden during and following treatments for cancer. Targeted cessation efforts for smokers to decrease symptom burden may limit the likelihood of treatment interruptions and increase quality of life following treatment.
Hair Loss Treatment at the Proctor clinic.
This is the long description for the blog named 'Blog A'.
|<< <||Current||> >>|